- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.58B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.44B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $5.18B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.04B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.85B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $7.39B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $13.57B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.85B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.02B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $3.12B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 405.48M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $17M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $553M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $7B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $6.81B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $319M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $279M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$23M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$61M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.51B |